Determining Therapeutic Approaches in the Elderly with Rectal Cancer

[1]  S. Dudrick,et al.  Long-Term Outcome After Operative Intervention for Rectal Cancer in Patients Aged Over 80 Years: Analysis of 9,501 Patients , 2007, Diseases of the colon and rectum.

[2]  M. Janssen-Heijnen,et al.  Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. , 2006, European journal of cancer.

[3]  E. Gore,et al.  Age Is Independent of Comorbidity Influencing Patient Selection for Combined Modality Therapy for Treatment of Stage III Nonsmall Cell Lung Cancer (NSCLC) , 2006, American journal of clinical oncology.

[4]  R. Audisio,et al.  Implications of Aging in Surgical Oncology , 2005, Cancer journal.

[5]  G. Lyman,et al.  Crawford J, Dale DC, Lyman GH. Chemotherapy‐induced neutropenia: risks, consequences, and new directions for its management. Cancer. (2004) 100(2):228–37. , 2004 .

[6]  R. Audisio,et al.  The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. , 2004, European journal of cancer.

[7]  G. Lyman,et al.  Chemotherapy‐induced neutropenia , 2004, Cancer.

[8]  M. Aapro,et al.  EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer. , 2003, European journal of cancer.

[9]  G. Lyman,et al.  Evidence-based use of colony-stimulating factors in elderly cancer patients. , 2003, Cancer control : journal of the Moffitt Cancer Center.

[10]  E. Gore,et al.  Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. , 2002, International journal of radiation oncology, biology, physics.

[11]  G. Lyman,et al.  Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patients , 2002, Current opinion in hematology.

[12]  V. Valentini,et al.  Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. , 2001, International journal of radiation oncology, biology, physics.

[13]  L. Walter,et al.  Cancer screening in elderly patients: a framework for individualized decision making. , 2001, JAMA.

[14]  C. Bokemeyer,et al.  Chemotherapy in elderly patients with colorectal cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  J. Guillem,et al.  Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. , 2001, International journal of radiation oncology, biology, physics.

[16]  A. Zbar,et al.  Surgical outcomes for colorectal cancer patients including the elderly. , 2001, Hepato-gastroenterology.

[17]  L. Balducci,et al.  The application of the principles of geriatrics to the management of the older person with cancer. , 2000, Critical reviews in oncology/hematology.

[18]  W. Hohenberger,et al.  Preoperative Radiation with Concurrent 5-Fluorouracil for Locally Advanced T4-Primary Rectal Cancer , 2000, Strahlentherapie und Onkologie.

[19]  A. Norman,et al.  Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  L. Stitt,et al.  Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. , 1998, International journal of radiation oncology, biology, physics.

[21]  H. Gómez,et al.  Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  T. Landberg,et al.  What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  G. Lyman,et al.  Comorbidity and functional status are independent in older cancer patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  D. Winchester,et al.  The National Cancer Data Base report on colon cancer , 1996, Cancer.

[25]  H. Thaler,et al.  Total mesorectal excision in the operative treatment of carcinoma of the rectum. , 1995, Journal of the American College of Surgeons.

[26]  Sati Mazumdar,et al.  Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale , 1992, Psychiatry Research.

[27]  H. Withers,et al.  Treatment volume and tissue tolerance. , 1988, International journal of radiation oncology, biology, physics.

[28]  Beahrs Oh,et al.  The American Joint Committee on Cancer. , 1984 .

[29]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[30]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[31]  A. Chan,et al.  Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study. , 2000, International journal of radiation oncology, biology, physics.

[32]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[33]  R. Rosso,et al.  Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy , 1998, Cancer Chemotherapy and Pharmacology.

[34]  N. Petrelli,et al.  Age and sex are independent predictors of 5‐fluorouracil toxicity. Analysis of a large scale phase III trial , 1995, Cancer.

[35]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.